19th Annual Winter Lung Cancer Conference

/ Print /
| ShareMore
/ Text Size +
2/4/22 7:00 pm to 2/6/22 12:30 pm EDT
Eden Roc Miami Beach + Virtual Webinar
United States

The 19th Annual Winter Lung Cancer Conference® is not to be missed!

We are pleased to invite you to the upcoming 19th Annual Winter Lung Cancer Conference®, a first-class CME event for the treatment of patients with lung cancer. Based on the popular format of expert overviews with dynamic Medical Crossfire® exchanges, this meeting will provide you with the most cutting-edge research and practical information for the care of your patients. You will also have a preview of new agents and techniques that will inform the future of lung cancer treatment.

 The learning objectives of this program are:

  • Evaluate molecular testing strategies to optimize treatment selection in patients with oncogene-driven NSCLC
  • Identify current and emerging approaches for patient selection and decision-making for immunotherapy and targeted agents
  • Outline clinical data on therapeutic approaches for early-stage and locally advanced lung cancer
  • Apply immunotherapeutic strategies to patients with thoracic malignancies along the continuum of disease
  • Explain the use of cytotoxic, targeted, and other systemic agents in the management of patients with lung cancer with or without oncogenic drivers
  • Determine approaches to mitigate and manage treatment-related adverse events in patients with lung cancer

Use code WLC35CME for 35 percent off!

Target Audience

This educational activity is intended for oncologists involved in the treatment and management of patients with lung cancer. Nurse practitioners, nurses, physician assistants, pharmacists, investigators, fellows, and other healthcare professionals interested in the treatment of lung cancer may also participate.


February 4, 2022 - February 6, 2022

7:00 PM - 12:30 PM


Program Chairs

Rogerio C. Lilenbaum, MD
Senior Physician Executive
Banner MD Anderson Cancer Center
Phoenix, AZ


Mark A. Socinski, MD
Executive Medical Director
AdventHealth Cancer Institute
Member, Thoracic Oncology Program
Orlando, FL


Julie R. Brahmer, MD, MSc, FASCO
Director, Thoracic Oncology Program
Kimmel Cancer Center at Johns Hopkins Bayview
Professor of Oncology
Johns Hopkins Kimmel Cancer Center
Baltimore, MD